| Malcolm Iain Smith, MD | |
|
200 Medical Plaza, #365,530,420,120, Los Angeles, CA 90095 | |
| (310) 449-0939 | |
| (310) 449-0977 |
| Full Name | Malcolm Iain Smith |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 33 Years |
| Location | 200 Medical Plaza, Los Angeles, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962422063 | NPI | - | NPPES |
| 00G773430 | Medicaid | CA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Santa Monica - Ucla Med Ctr & Orthopaedic Hospital | Santa monica, CA | Hospital |
| West Hills Hospital & Medical Center | West hills, CA | Hospital |
| Ronald Reagan Ucla Medical Center | Los angeles, CA | Hospital |
| Henry Mayo Newhall Hospital | Valencia, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Regents Of The University Of California | 1355248584 | 1177 |
News Archive
Reuters and The Wall Street Journal challenge the notion, based on recent jobs data, that the health law is causing an erosion of full-time work. Other media outlets look at the endangered status of new insurance co-ops funded by the law, the high price of many prescription drugs and concerns about the people enrolled in high-risk insurance pools that will close at the end of the year.
Illinois Attorney General Lisa Madigan and Department of Financial and Professional Regulation Secretary Fernando Grillo today announced a suit has been filed against a Florida-based online pharmacy that illegally prescribed the powerful painkiller Vicodin to an employee in Madigan's office posing as a consumer who had injured his back after slipping on ice.
In a meta-analysis of hundreds of clinical trials involving thousands of patients, researchers at University of California San Diego School of Medicine report that therapeutic approaches using precision medicine, which emphasizes the use of individual genetics to refine cancer treatment, showed improved response and longer periods of disease remission, even in phase I trials.
Merz Pharmaceuticals today announced that the United States Food and Drug Administration has approved Xeomin (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm. According to an epidemiology study conducted in Rochester, Minnesota, the prevalence of focal dystonia, which includes cervical dystonia and blepharospasm, is estimated at 295 per million people in the U.S.
› Verified 4 days ago
| Entity Name | The Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235107566 PECOS PAC ID: 1355248584 Enrollment ID: O20031223000439 |
News Archive
Reuters and The Wall Street Journal challenge the notion, based on recent jobs data, that the health law is causing an erosion of full-time work. Other media outlets look at the endangered status of new insurance co-ops funded by the law, the high price of many prescription drugs and concerns about the people enrolled in high-risk insurance pools that will close at the end of the year.
Illinois Attorney General Lisa Madigan and Department of Financial and Professional Regulation Secretary Fernando Grillo today announced a suit has been filed against a Florida-based online pharmacy that illegally prescribed the powerful painkiller Vicodin to an employee in Madigan's office posing as a consumer who had injured his back after slipping on ice.
In a meta-analysis of hundreds of clinical trials involving thousands of patients, researchers at University of California San Diego School of Medicine report that therapeutic approaches using precision medicine, which emphasizes the use of individual genetics to refine cancer treatment, showed improved response and longer periods of disease remission, even in phase I trials.
Merz Pharmaceuticals today announced that the United States Food and Drug Administration has approved Xeomin (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm. According to an epidemiology study conducted in Rochester, Minnesota, the prevalence of focal dystonia, which includes cervical dystonia and blepharospasm, is estimated at 295 per million people in the U.S.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Malcolm Iain Smith, MD 5767 W Century Blvd, Suite 400, Los Angeles, CA 90045-5632 Ph: (310) 449-0939 | Malcolm Iain Smith, MD 200 Medical Plaza, #365,530,420,120, Los Angeles, CA 90095 Ph: (310) 449-0939 |
News Archive
Reuters and The Wall Street Journal challenge the notion, based on recent jobs data, that the health law is causing an erosion of full-time work. Other media outlets look at the endangered status of new insurance co-ops funded by the law, the high price of many prescription drugs and concerns about the people enrolled in high-risk insurance pools that will close at the end of the year.
Illinois Attorney General Lisa Madigan and Department of Financial and Professional Regulation Secretary Fernando Grillo today announced a suit has been filed against a Florida-based online pharmacy that illegally prescribed the powerful painkiller Vicodin to an employee in Madigan's office posing as a consumer who had injured his back after slipping on ice.
In a meta-analysis of hundreds of clinical trials involving thousands of patients, researchers at University of California San Diego School of Medicine report that therapeutic approaches using precision medicine, which emphasizes the use of individual genetics to refine cancer treatment, showed improved response and longer periods of disease remission, even in phase I trials.
Merz Pharmaceuticals today announced that the United States Food and Drug Administration has approved Xeomin (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm. According to an epidemiology study conducted in Rochester, Minnesota, the prevalence of focal dystonia, which includes cervical dystonia and blepharospasm, is estimated at 295 per million people in the U.S.
› Verified 4 days ago
Dr. Linda Fong, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-3290 | |
Dr. Robert Peter Gale, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 11693 San Vicente Blvd, Suite 335, Los Angeles, CA 90049 Phone: 310-442-9010 | |
Dr. Tarek Alasil, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8616 La Tijera Blvd Ste 404, Los Angeles, CA 90045 Phone: 310-673-2020 Fax: 310-469-5290 | |
David Michael Tellalian, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8635 W 3rd St Ste 465w, Los Angeles, CA 90048 Phone: 310-358-2300 Fax: 310-358-2308 | |
Dr. Jan B King, M.D., M.P.H. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 11833 Wilmington Ave Fl 2, Los Angeles, CA 90059 Phone: 323-568-8701 | |
Dr. Caroline Hwang, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1520 San Pablo St, Suite 1000, Los Angeles, CA 90033 Phone: 323-442-5100 | |
Dr. Jennifer A Fulcher, M.D., PH.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 10833 Le Conte Ave, Chs 37-121, Los Angeles, CA 90095 Phone: 310-825-7225 |